Ayala Pharmaceuticals Inc (OTCQX US:ADXS)
| 1.35 Delayed Data As of Mar 24 |  -0.15 / -10.00%Today’s Change | 1.00 Today|||52-Week Range 10.71 | +12.50% Year-to-Date |
Latest ADXS News | Press Releases
No recent news for Ayala Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.50 |
| Today’s open | 1.30 |
| Day’s range | 1.30 - 1.40 |
| Volume | 1,041 |
| Average volume (3 months) | 6,434 |
| Market cap | $6.5M |
Data as of 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +23.58% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -92.28% |
| P/E ratio | -- |
| Price/Sales | 13.53 |
| Price/Book | 0.10 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $250.0K |
| Annual profit (last year) | -$14.4M |
| Net profit margin | -5,743.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Princeton, New Jersey |
Forecasts
Chart unavailable
